Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.404 Factor de Impacto de 5 años: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumes:
Volumen 40, 2020 Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v30.i3.30
pages 255-270

New Technologies in Using Recombinant Attenuated Salmonella Vaccine Vectors

Roy Curtiss III
The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona
Wei Xin
The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona
Yuhua Li
The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona
Wei Kong
The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona
Soo-Young Wanda
The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona
Bronwyn Gunn
The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona
Shifeng Wang
The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona

SINOPSIS

Recombinant attenuated Salmonella vaccines (RASVs) have been constructed to deliver antigens from other pathogens to induce immunity to those pathogens in vaccinated hosts. The attenuation means should ensure that the vaccine survives following vaccination to colonize lymphoid tissues without causing disease symptoms. This necessitates that attenuation and synthesis of recombinant gene encoded protective antigens do not diminish the ability of orally administered vaccines to survive stresses encountered in the gastrointestinal tract. We have eliminated these problems by using RASVs with regulated delayed expression of attenuation and regulated delayed synthesis of recombinant antigens. These changes result in RASVs that colonize effector lymphoid tissues efficiently to serve as "factories" to synthesize protective antigens that induce higher protective immune responses than achieved when using previously constructed RASVs. We have devised a biological containment system with regulated delayed lysis to preclude RASV persistence in vivo and survival if excreted. Attributes were added to reduce the mild diarrhea sometimes experienced with oral live RASVs and to ensure complete safety in newborns. These collective technologies have been used to develop a novel, low-cost, RASV-synthesizing, multiple-protective Streptococcus pneumoniae antigens that will be safe for newborns/infants and will induce protective immunity to diverse S. pneumoniae serotypes after oral immunization.


Articles with similar content:

Management and Prevention of Tetanus
Journal of Long-Term Effects of Medical Implants, Vol.13, 2003, issue 3
Lisa G. Hill, Richard Edlich, Daniel G. Becker, Larry S. Nichter, Jed H. Horowitz, Mary Jude Cox, Chandra A. Mahler, William C. Lineaweaver, Marcus L. Martin
Regulation Generation: The Suppressive Functions of Human Regulatory T Cells
Critical Reviews™ in Immunology, Vol.32, 2012, issue 1
Kevin D. Cooper, Thomas S. McCormick, Wendy A. Goodman
Natural IgM and the Development of B Cell-Mediated Autoimmune Diseases
Critical Reviews™ in Immunology, Vol.36, 2016, issue 2
Nicole Baumgarth, Trang T. T. Nguyen
p53-Based Immunotherapy of Cancer
Critical Reviews™ in Immunology, Vol.18, 1998, issue 1-2
Albert B. DeLeo
Transcutaneous Immunization: An Emerging Route of Immunization and Potent Immunostimulation Strategy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.18, 2001, issue 5
Scott A. Hammond, Gregory M. Glenn, Mimi Guebre-Xabier, Jianmei Yu